Immuneering/$IMRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Immuneering
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
- Ticker
- $IMRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 57
- Headquarters
- Cambridge, United States
- Website
- immuneering.com
Immuneering Metrics
BasicAdvanced
$311m
-
-$0.98
0.37
-
Price and volume
Market cap
$311m
Beta
0.37
52-week high
$10.08
52-week low
$2.90
Average daily volume
828k
Financial strength
Current ratio
19.467
Quick ratio
18.471
Long term debt to equity
1.68
Total debt to equity
1.905
Profitability
EBITDA (TTM)
-63.119
Management effectiveness
Return on assets (TTM)
-32.77%
Return on equity (TTM)
-52.15%
Valuation
Price to book
1.63
Price to tangible book (TTM)
1.69
Price to free cash flow (TTM)
-4.925
Free cash flow yield (TTM)
-20.31%
Free cash flow per share (TTM)
-0.975
Growth
Earnings per share change (TTM)
-47.80%
3-year earnings per share growth (CAGR)
-20.14%
What the Analysts think about Immuneering
Analyst ratings (Buy, Hold, Sell) for Immuneering stock.
Immuneering Financial Performance
Revenues and expenses
Immuneering Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.